Former Deputy Commissioner of New York State Department of Health Joins Sheppard Mullin
Adam Herbst has joined Sheppard Mullin as a healthcare partner in New York, becoming the ninth healthcare partner to join in 2024. Previously serving as New York State Department of Health's Deputy Commissioner for Aging and Long Term Care, Herbst brings expertise in healthcare policy, Medicaid reform, and corporate governance. His experience includes overseeing regulation for New York's acute care, post-acute care, disability, and long-term care industries. The firm highlights its active long-term care practice, citing recent major transactions including a strategic partnership with Elevance Health and various joint ventures in the healthcare sector.
Adam Herbst è entrato a far parte di Sheppard Mullin come partner nel settore sanitario a New York, diventando il nono partner sanitario a unirsi nel 2024. In precedenza ha ricoperto il ruolo di Vice Commissario per l'Invecchiamento e la Cura a Lungo Termine presso il Dipartimento della Salute dello Stato di New York. Herbst porta con sé una vasta esperienza in politica sanitaria, riforma del Medicaid e governance aziendale. La sua esperienza include la supervisione della regolamentazione dei settori della cura acuta, cura post-acuta, disabilità e assistenza a lungo termine di New York. Lo studio legale sottolinea la sua attiva pratica nell'assistenza a lungo termine, citando recenti transazioni rilevanti, tra cui una partnership strategica con Elevance Health e vari joint venture nel settore sanitario.
Adam Herbst se ha unido a Sheppard Mullin como socio en el área de salud en Nueva York, convirtiéndose en el noveno socio de salud en unirse en 2024. Anteriormente, se desempeñó como Comisionado Adjunto del Departamento de Salud del Estado de Nueva York para el Envejecimiento y la Asistencia a Largo Plazo, y aporta experiencia en políticas de salud, reforma de Medicaid y gobernanza corporativa. Su experiencia incluye la supervisión de la regulación de las industrias de atención aguda, atención post-aguda, discapacidad y atención a largo plazo en Nueva York. La firma destaca su activa práctica en asistencia a largo plazo, citando transacciones importantes recientes que incluyen una asociación estratégica con Elevance Health y diversas empresas conjuntas en el sector salud.
아담 허브스트가 뉴욕의 Sheppard Mullin에 의료 파트너로 합류하여, 2024년에 합류한 아홉 번째 의료 파트너가 되었습니다. 그는 이전에 뉴욕주 보건부의 고령자 및 장기 요양 부국장을 역임하며 의료 정책, Medicaid 개혁 및 기업 거버넌스에 대한 전문성을 가지고 있습니다. 그의 경험은 뉴욕의 급성 치료, 후속 치료, 장애인 및 장기 요양 산업에 대한 규제를 감독하는 것을 포함합니다. 이 법인은 최근 Elevance Health와의 전략적 파트너십 및 의료 분야의 여러 합작 투자를 포함하여, 활성화된 장기 요양 실무를 강조합니다.
Adam Herbst a rejoint Sheppard Mullin en tant que partenaire dans le secteur de la santé à New York, devenant ainsi le neuvième partenaire en santé à se joindre en 2024. Auparavant, il a été Commissaire adjoint du Département de la Santé de l'État de New York pour le vieillissement et les soins de longue durée, apportant son expertise en matière de politique de santé, de réforme de Medicaid et de gouvernance d'entreprise. Son expérience inclut la supervision de la réglementation des secteurs de soins aigus, de soins post-aigus, de handicap et de soins de longue durée à New York. Le cabinet met en avant sa pratique active dans le domaine des soins de longue durée, citant des transactions majeures récentes, y compris un partenariat stratégique avec Elevance Health et diverses coentreprises dans le secteur de la santé.
Adam Herbst ist als Partner im Gesundheitswesen zu Sheppard Mullin in New York gestoßen und wird der neunte Gesundheitspartner, der 2024 beitritt. Zuvor war er stellvertretender Kommissar des Gesundheitsministeriums des Bundesstaates New York für Alter und Langzeitpflege und bringt umfangreiche Kenntnisse im Bereich Gesundheitspolitik, Medicaid-Reform und Unternehmensführung mit. Seine Erfahrung umfasst die Aufsicht über die Regulierung der akuten, post-akuten, behinderten und langfristigen Pflegebranche in New York. Die Kanzlei hebt ihre aktive Praxis im Bereich Langzeitpflege hervor und nennt dabei bedeutende kürzliche Transaktionen, einschließlich einer strategischen Partnerschaft mit Elevance Health und verschiedenen Joint Ventures im Gesundheitssektor.
- Strengthens firm's healthcare regulatory expertise with high-profile hire
- Expands capabilities in post-acute, aging, and long-term care sectors
- Recent successful completion of multibillion-dollar strategic partnership with Elevance Health
- None.
Insights
The appointment of Adam Herbst to Sheppard Mullin represents a significant development in healthcare legal services, particularly given the firm's recent high-profile work with Elevance Health (ELV). The firm's involvement in the
This move strengthens Sheppard Mullin's capabilities in advising on healthcare regulatory compliance and strategic transactions, particularly in the growing post-acute care sector. For Elevance Health investors, this indicates enhanced legal support for future strategic initiatives and regulatory compliance in their healthcare services expansion.
Nationally Recognized Healthcare Policy Leader Adam Herbst Strengthens the Firm’s Regulatory Capabilities for Clients Across the Post-Acute, Aging and Long-Term Care Sectors
Adam Herbst (Photo: Business Wire)
In joining Sheppard Mullin’s industry-leading Healthcare team, Herbst specializes in healthcare policy, Medicaid reform and corporate governance, with a strong focus on transforming healthcare systems to ensure equitable access and improved quality for diverse populations, including children, seniors and individuals with disabilities.
As Deputy Commissioner for Aging and Long Term Care at the Department of Health, Herbst oversaw regulation for the state of New York’s acute care, post-acute care, disability and long-term care industries. As an advisor to the Governor of
He served as the Commissioner’s Special Advisor where he developed and implemented comprehensive policies and programs aimed at strengthening New York’s health systems and payors. His efforts addressed the diverse needs of communities statewide, particularly in the wake of COVID-19, ensuring that all New Yorkers had equitable access to quality healthcare services. Adam’s initiatives spanned various demographics, focusing on improving health outcomes and enhancing service delivery for vulnerable populations, including aging individuals, those with disabilities and other underserved communities. He has also implemented initiatives that incentivize healthcare providers to deliver high-value services, particularly for dual-eligible individuals who often face complex healthcare challenges.
In addition to his regulatory and policy work, Herbst has a strong transactional background, having been involved in numerous mergers and acquisitions within the healthcare sector. He has a proven track record of facilitating partnerships and collaborations that enhance service delivery and operational efficiency. His advocacy for integrated care models fosters collaboration among providers to improve care coordination and patient outcomes. With decades of healthcare regulatory expertise, Herbst is adept at creating alignment strategies for Medicare, Medicaid and other government payer programs.
“Adam is a nationally recognized leader in the healthcare industry, and we are delighted to welcome him to the firm.” said Luca Salvi, chair of Sheppard Mullin. “His multi-dimensional understanding of the marketplace and deep knowledge advising healthcare companies through strategic investments will be invaluable to our clients.”
Eric Klein, leader of the firm’s Healthcare industry team added, “The aging population is fueling significant opportunities in the post-acute care sector, including the expansion of existing and creation of new providers, funding and regulation. Adam’s reputation and exceptional experience further cements Sheppard Mullin’s as the destination for top-tier regulatory and compliance counsel across the aging, hospital care and long-term care sectors.”
“The regulatory landscape for post-acute care providers is complex and ripe for change,” added Herbst. “I was drawn to the size and reputation of Sheppard Mullin’s nationally known, comprehensive healthcare practice. The attorneys and resources at the firm will allow me to continue providing innovative advice to clients as we navigate the evolving healthcare environment.”
Sheppard Mullin has one of the country’s most active long-term care and post-acute care practices, representing all segments of this industry. Recent examples include:
- Represented private equity firm Clayton, Dubilier & Rice in forming a multibillion-dollar strategic partnership with Elevance Health, Inc. (NYSE: ELV). One of the two largest healthcare services transactions in 2024, the deal launched a new advanced primary care solution that streamlines the patient experience, improves health outcomes and lowers healthcare costs, particularly for the senior population.
-
In one of the largest home health and hospice transactions of the year, Sheppard Mullin is representing leading home-based care service provider, Compassus, in its joint venture with nonprofit health system Providence that will offer home health, hospice and palliative care to patients across
Alaska ,California ,Oregon ,Washington andTexas . -
Advised AccentCare, nationwide post-acute healthcare services leader, in several transactional, regulatory and financing matters, including its acquisition of and joint venture with Memorial Hermann’s home health and hospice operations; joint venture with and acquisition of
Fairview health system’s home health and hospice line of business; home health and hospice joint venture with Baylor Scott & White Health, the largest not-for-profit health system inTexas ; and joint ventures with University ofCalifornia ,San Diego and the University ofCalifornia ,Los Angeles .
- Advised post-acute and specialty home health provider Collage Rehabilitation Partners in its acquisition of Omicron Care, a home health provider to patients with catastrophic injuries including, stroke and neurologic disorders. The acquisition expanded Collage’s national continuum of care in new and existing markets.
Herbst received his B.A., summa cum laude, from American University, his J.D. from Albany Law School, and his M.B.A. from Union College. He is a frequent speaker on healthcare access and technology and currently serves as an adjunct professor at Columbia University’s Mailman School of Public Health and at New York Law School, teaching health policy and bioethics.
About Sheppard Mullin’s Healthcare Team
Sheppard Mullin’s 260-attorney national healthcare industry team has been named a Health Care Practice Group of the Year by Law360 three times in seven years. Working in all sectors of healthcare with industry-leading and growing companies, disruptive start-up clients and healthcare-focused investors, Sheppard Mullin is a go-to firm for innovative transactions and joint ventures, regulatory solutions, population health management, global risk and value-based contracting, technology transactions and privacy matters. The team offers significant experience in cybersecurity, tax, non-profit, employment and labor, real estate, artificial intelligence, antitrust, litigation and finance.
About Sheppard, Mullin, Richter & Hampton LLP
Sheppard Mullin is a full-service AmLaw 50 firm with more than 1,100 attorneys in 16 offices located in
View source version on businesswire.com: https://www.businesswire.com/news/home/20241030758975/en/
LORENA LOPEZ
(619) 338-6650
ilopez@sheppardmullin.com
KARA EYER
(312) 499-0533
keyer@sheppardmullin.com
Source: Sheppard, Mullin, Richter & Hampton LLP
FAQ
What is Adam Herbst's role at Sheppard Mullin and how does it relate to Elevance Health (ELV)?
How many healthcare partners has Sheppard Mullin added in 2024?
What was Adam Herbst's previous position before joining Sheppard Mullin?
